Ramelteon is a selective melatonin receptor agonist primarily used for the treatment of insomnia. As a non-benzodiazepine hypnotic, it regulates the sleep-wake cycle by mimicking natural melatonin and exhibits unique mechanisms of action and efficacy characteristics.
Indications of Ramelteon
Core Indications
Ramelteon has been approved by the FDA for the treatment of insomnia characterized by difficulty falling asleep.
Clinical studies have confirmed that it can significantly reduce sleep latency (time to fall asleep).
Use Restrictions
It is not recommended for patients with severe sleep apnea due to the lack of safety data in this population.
It is not suitable for patients with existing severe hepatic impairment (Child-Pugh Class C); caution is required for patients with moderate hepatic impairment.
It is not indicated for children and adolescents.
Specifications and Characteristics of Ramelteon
Dosage Form and Specifications
Ramelteon is currently only available as 8mg film-coated tablets.
Appearance: Round, light orange-yellow tablets.
Imprint: One side is imprinted with "TAK" and "RAM-8".
Excipients: Include lactose monohydrate, starch, hydroxypropyl cellulose, etc.
Pharmacological Properties
As a highly selective MT1/MT2 receptor agonist, it maintains the normal circadian rhythm by regulating melatonin receptors in the suprachiasmatic nucleus of the hypothalamus.
It has no GABA receptor-binding activity.
The exposure of its metabolite M-II (the main active metabolite) is 20-100 times that of the parent drug.
Pharmacokinetics
Absorption: The peak plasma concentration is reached 0.5-1.5 hours after oral administration; high-fat meals delay absorption by 45 minutes.
Metabolism: It is mainly oxidized by CYP1A2, with minor metabolic pathways involving CYP2C/CYP3A4.
Half-life: 1-2.6 hours for the parent drug, and 2-5 hours for the M-II metabolite.
Storage Methods of Ramelteon
Routine Storage Requirements
The drug should be stored at room temperature between 20°C and 25°C (68°F to 77°F). Short-term transportation or storage within the range of 15°C to 30°C (59°F to 86°F) is permitted.
It should be protected from light and moisture. The original packaging (such as aluminum blister packs or bottles) should be retained to prevent physical or chemical degradation of the tablets.
Special Precautions
Avoid high-temperature or humid environments (e.g., bathrooms, kitchens) to prevent inactivation of the drug components.
The drug does not require special cold chain storage, but it should be kept out of the reach of children and pets.
Stability Description
Unopened ROZEREM tablets remain stable within the labeled expiration date. Once opened, it is recommended to use the drug as soon as possible.
